MedPath

The effect of newly somatostatin analogues for neuroendocrine tumor

Not Applicable
Conditions
neuroendocrine tumor
Registration Number
JPRN-UMIN000028537
Lead Sponsor
Tokushima University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

non

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath